Formerly known as ACTAVIS PHARMA COMPANY
Shortage reports
Actual shortage:
280 (9%)
Anticipated shortage:
6 (0%)
Avoided shortage:
10 (0%)
Resolved:
2981 (91%)
3277
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
484 (13%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-07-02 | 2021-10-14 | 88216 |
| TEVA-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-10-22 | 2020-12-17 | 126927 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-31 | 2019-04-11 | 59708 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-08-31 | 2019-04-11 | 59711 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-06-20 | 2023-07-05 | 195800 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2025-09-18 | 2026-01-15 | 267463 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-10-17 | 2022-12-08 | 172021 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-04-27 | 2023-12-14 | 190770 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-12-10 | 2021-02-12 | 129981 |
| TEVA-PAROXETINE | 30MG | TABLET | Actual shortage | 2026-02-05 | 2026-02-05 | 277363 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1167 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1161 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2019-12-09 | 2025-01-23 | 100550 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2019-12-09 | 2025-01-23 | 100553 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1179 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1191 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1199 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1204 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1454 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1153 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |